The Gastroparesis Cardinal Symptom Index scores trended lower in MASLD patients (12.69 ± 5.80) compared to controls (16.12 ± 5.17) (t = 1.88, p = 0.071), but this difference did not reach statistical significance (p = 0.071) (Figure 2 ).
← all excerpts
Gastric Myoelectric Activity in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Case-Control Study.
1
0.0710
0.0710